GoodRx Launches New E-commerce Platform, Debuts with Opill

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., has announced the launch of its new e-commerce solution, beginning with Opill® as its debut partner. This user-friendly direct-to-consumer platform allows consumers to order eligible health products and medications directly through GoodRx, with home delivery options. By entering the over-the-counter (OTC) market, GoodRx offers new partnership opportunities for health and pharmaceutical brands to leverage its extensive consumer reach.

“We are thrilled to launch our e-commerce solution with Opill, reinforcing our shared commitment to making healthcare more accessible,” says Dorothy Gemmell, Chief Commercial Officer at GoodRx.

With the introduction of this e-commerce platform, GoodRx enhances its strategy of integrating health and wellness brands, offering consumers a convenient option to order Opill contraception directly to their homes without needing a doctor’s visit or prescription. The new service aims to create a seamless shopping experience for consumer health brands looking to engage GoodRx’s broad audience and enhance market presence.

The GoodRx-Opill collaboration addresses healthcare access barriers, especially for the over 19 million women in areas with limited contraceptive services. By eliminating cost and logistical hurdles, this initiative empowers women to manage their reproductive health independently and conveniently.

“Perrigo worked extensively to make daily oral birth control accessible without a prescription,” explains Sara Young, SVP and Chief Growth and Transformation Officer at Perrigo, the manufacturer of Opill. “Partnering with GoodRx allows us to reach more women who need a simple way to access Opill, the most effective non-prescription birth control currently available.”

GoodRx’s e-commerce launch aligns with the growing consumer preference for autonomy in healthcare management, accelerated by the pandemic. By addressing traditional healthcare challenges, GoodRx aims to empower consumers to manage their health more independently while providing a platform for partners to enhance medication visibility and accessibility.

For more information on Opill’s safety and usage, please visit Opill.com.

About GoodRx

GoodRx is a leading U.S. prescription savings platform, trusted by over 25 million consumers and 750,000 healthcare professionals annually. Offering significant savings on both generic and brand-name medications across more than 70,000 pharmacies, GoodRx has saved consumers over $75 billion since 2011. Investors and consumers can find important updates on GoodRx’s investor relations website at https://investors.goodrx.com.


Forward-Looking Statements: This release contains forward-looking statements regarding anticipated consumer benefits, the impact of GoodRx’s e-commerce platform, and future company initiatives. These statements involve risks and uncertainties, which are discussed under “Risk Factors” in GoodRx’s SEC filings. GoodRx assumes no obligation to update these statements following this release.

Source link

Share your love

Newsletter Updates

Enter your email address below and subscribe to our newsletter